28/05/14

Q&A: How genomics can tackle antimicrobial resistance

Scientist examining DNA (FILEminimizer).jpg

Copyright: Wellcome Photo Library, Wellcome Images

By: Cristina Gallardo

We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:

You have to credit our authors.
You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
The easiest way to get the article on your site is to embed the code below.

For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

<div class="article-wrap">
<div id="article-introduction">
<h1>Q&A: How genomics can tackle antimicrobial resistance</h1>
<h4>By: Cristina Gallardo</h4>
</div>
<br />
<br />

<div id="article-body">
<p><iframe loading="lazy" frameborder="no" height="450" scrolling="no" src="https://w.soundcloud.com/player/?url=https%3A//api.soundcloud.com/tracks/151657823&auto_play=false&hide_related=false&visual=true" width="100%"></iframe></p>
<p>Antimicrobial resistance is a major threat to human health as it is reducing the effectiveness of antibiotics used to treat bacterial infections such as pneumonia or <a href="https://www.scidev.net/health/tb/">tuberculosis</a>.<br />
 <br />
Last week, a panel of scientists discussed the issue in a meeting at the Royal Society in London, United Kingdom. Julian Parkhill, who researches pathogens at the University of Cambridge, United Kingdom, talked about how genetics offers opportunities to tackle antimicrobial resistance.<br />
 <br />
He said that by <a href="https://www.scidev.net/health/genomics/">decoding the genomes</a> of a large number of bacteria, scientists will be able to understand how common pathogens respond to antibiotics and what genetic changes drive them to become resistant. They can therefore predict how resistance will develop and design strategies that could save millions of people, particularly in <a href="https://www.scidev.net/governance/vulnerability/">vulnerable areas</a> such as developing countries, where <a href="https://www.scidev.net/health/">healthcare</a> infrastructure is more basic.</p>

</div>
<div class="quick-links-wrapper">
<h3>You might also like</h3>
[related-articles]
</div>
<p>This article was originally published on <a href="https://www.scidev.net" target="_blank">SciDev.Net</a>. Read the <a href="https://www.scidev.net/global/multimedia/genomics-antimicrobial-resistance/" target="_blank">original article</a>.</p>
<script type="text/javascript">
(function(e,t,n,r,i,s,o){e["GoogleAnalyticsObject"]=i;e[i]=e[i]||function(){(e[i].q=e[i].q||[]).push(arguments)},e[i].l=1*new Date;s=t.createElement(n),o=t.getElementsByTagName(n)[0];s.async=1;s.src=r;o.parentNode.insertBefore(s,o)})(window,document,"script","//www.google-analytics.com/ga.js","ga");var _gaq=_gaq||[];var _gaq=_gaq||[];_gaq.push(["_setAccount","UA-3223906-8"],["_trackEvent","article interaction","republished","https://www.scidev.net/global/multimedia/genomics-antimicrobial-resistance/",null,true])
</script>
</div>

Antimicrobial resistance is a major threat to human health as it is reducing the effectiveness of antibiotics used to treat bacterial infections such as pneumonia or tuberculosis.

Last week, a panel of scientists discussed the issue in a meeting at the Royal Society in London, United Kingdom. Julian Parkhill, who researches pathogens at the University of Cambridge, United Kingdom, talked about how genetics offers opportunities to tackle antimicrobial resistance.

He said that by decoding the genomes of a large number of bacteria, scientists will be able to understand how common pathogens respond to antibiotics and what genetic changes drive them to become resistant. They can therefore predict how resistance will develop and design strategies that could save millions of people, particularly in vulnerable areas such as developing countries, where healthcare infrastructure is more basic.